Literature DB >> 25511373

Prevalence of rheumatic heart disease in young adults from New Caledonia.

Pierre-Henri Ledos1, Joel Kamblock2, Pierre Bourgoin2, Philippe Eono3, Jonathan R Carapetis4.   

Abstract

BACKGROUND: Rheumatic heart disease (RHD) is an important public health issue, particularly in the Pacific region, but its true burden is unknown.
OBJECTIVES: To evaluate the prevalence of rheumatic heart disease (RHD) in young adults from New Caledonia, based on echocardiography, and to evaluate the accuracy of dynamic criteria, focusing on mitral valve (MV) leaflet motion.
METHODS: Blind analysis of echocardiography by three cardiologists; diagnosis of RHD required at least one dynamic criterion (exaggerated or restricted MV leaflet motion); subjects with morphological criteria (MV leaflet thickening), but without dynamic criteria, were considered as borderline.
RESULTS: There were 834 subjects from three socioeconomic groups, aged 18-22 years: 699 had normal echocardiography; 93 (11.5%) had physiological regurgitation; nine (0.9%) had borderline RHD; and five (0.59%) had RHD. The prevalence of RHD in New Caledonia was thus estimated at 5.9 per 1000 (95% confidence interval 2.6-12.2). The RHD cases were of Pacific ethnicity. Physiological regurgitation was more frequent in Pacific subjects (13.7%) than in non-Pacific subjects (6.9%; P<0.0001). RHD was more prevalent in the lowest socioeconomic group. No disagreement occurred between the three reviewers concerning analysis of dynamic criteria; all disagreements were related to morphological criteria.
CONCLUSIONS: The prevalence of echocardiographically diagnosed RHD in adults in New Caledonia is estimated at 5.9 per 1000; it occurs most frequently in Pacific subjects and those with low incomes. Dynamic criteria were more accurate and reproducible than standard morphological criteria.
Copyright © 2014 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Adult; Adulte; Dépistage; Echocardiography; Public health; Rheumatic heart disease; Santé publique; Screening; Valvulopathie rhumatismale; Échocardiographie

Mesh:

Year:  2014        PMID: 25511373     DOI: 10.1016/j.acvd.2014.07.053

Source DB:  PubMed          Journal:  Arch Cardiovasc Dis        ISSN: 1875-2128            Impact factor:   2.340


  6 in total

Review 1.  Group A Streptococcus, Acute Rheumatic Fever and Rheumatic Heart Disease: Epidemiology and Clinical Considerations.

Authors:  Liesl J Zühlke; Andrea Beaton; Mark E Engel; Christopher T Hugo-Hamman; Ganesan Karthikeyan; Judith M Katzenellenbogen; Ntobeko Ntusi; Anna P Ralph; Anita Saxena; Pierre R Smeesters; David Watkins; Peter Zilla; Jonathan Carapetis
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-02

2.  Paediatric acute rheumatic fever in developed countries: Neglected or negligible disease? Results from an observational study in Lombardy (Italy).

Authors:  Viorica Munteanu; Antonella Petaccia; Nicolae Contecaru; Emanuele Amodio; Carlo Virginio Agostoni
Journal:  AIMS Public Health       Date:  2018-05-23

3.  Profile of newly diagnosed adult patients with rheumatic heart disease in sub-Himalayan region - A 5-year analysis.

Authors:  Minakshi Dhar; Nidhi Kaeley; Nowneet Bhatt; Sohaib Ahmad
Journal:  J Family Med Prim Care       Date:  2019-09-30

4.  Prevalence and progression of rheumatic heart disease: a global systematic review and meta-analysis of population-based echocardiographic studies.

Authors:  Jean Jacques Noubiap; Valirie N Agbor; Jean Joel Bigna; Arnaud D Kaze; Ulrich Flore Nyaga; Bongani M Mayosi
Journal:  Sci Rep       Date:  2019-11-19       Impact factor: 4.379

Review 5.  The role of social determinants of health in the risk and prevention of group A streptococcal infection, acute rheumatic fever and rheumatic heart disease: A systematic review.

Authors:  Pasqualina M Coffey; Anna P Ralph; Vicki L Krause
Journal:  PLoS Negl Trop Dis       Date:  2018-06-13

6.  Screening Rheumatic Heart Disease in 1530 New Caledonian Adolescents.

Authors:  Jean-Claude Chatard; Thomas Dubois; Florian Espinosa; Joël Kamblock; Pierre-Henri Ledos; Emmanuel Tarpinian; Antoine Da Costa
Journal:  J Am Heart Assoc       Date:  2020-04-26       Impact factor: 5.501

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.